3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
2
Brain Neoplasms
2
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Magnetic Resonance Spectroscopy
13
Temozolomide
11
Specimen Handling
8
X-Rays
7
Biopsy
7
Nuclear Medicine Department, Hospital
6
Radiation
5
Phantoms, Imaging
5
erdafitinib
4
ulixertinib
3
trametinib
3
larotrectinib
3
dabrafenib
3
Radiotherapy
3
tipifarnib
2
selpercatinib
2
palbociclib
2
olaparib
2
ivosidenib
2
ensartinib
2
binimetinib
2
D2C7-(scdsFv)-PE38KDEL
2
vorasidenib
1
veliparib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tazemetostat
1
selinexor
1
sapanisertib
1
ruxolitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
Receptors, Interleukin-8B
×
30 days
×
Clear all
NCT06946680
2026-05-22
Peds IMPACT
University of Florida
Phase 1
Not yet recruiting
24 enrolled